DNA Methylation and mRNA Expression of B7-H3 Gene in Ankylosing Spondylitis: A Case-Control Study

References

• Arends S, Spoorenberg A, Efde M, Bos R, Leijsma MK, Bootsma H, Veeger NJGM, Brouwer E, van der Veer E, et al. 2014. Higher bone turnover is related to spinal radiographic damage and low bone mineral density in ankylosing spondylitis patients with active disease: a cross-sectional analysis. PloS ONE. 9(6):e99685.
   PubMed Web of Science ®Google Scholar
• Aslani S, Mahmoudi M, Garshasbi M, Jamshidi AR, Karami J, Nicknam MH. 2016. Evaluation of DNMT1 gene expression profile and methylation of its promoter region in patients with ankylosing spondylitis. Clin Rheumatol. 35(11):2723–31.
   PubMed Web of Science ®Google Scholar
• Brandt B, Rashidiani S, Bán Á, Rauch TA. 2019. DNA methylation-governed gene expression in autoimmune arthritis. Int J Mol Sci. 20(22):5646.
   Web of Science ®Google Scholar
• Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, Madden TL. 2009. BLAST+: architecture and applications. BMC Bioinform. 10(1):421.
   PubMed Web of Science ®Google Scholar
• Chapoval AI, Ni J, Lau JS, Wilcox RA, Flies DB, Liu D, Dong H, Sica GL, Zhu G, Tamada K, et al. 2001. B7-H3: a costimulatory molecule for T cell activation and IFN-γ production. Nat Immunol. 2(3):269–74.
   PubMed Web of Science ®Google Scholar
• Chen M, Wu M, Hu X, Yang J, Han R, Ma Y, Zhang X, Yuan Y, Liu R, Jiang G, et al. 2019. Ankylosing spondylitis is associated with aberrant DNA methylation of IFN regulatory factor 8 gene promoter region. Clin Rheumatol. 38(8):2161–69.
   PubMed Web of Science ®Google Scholar
• Chen Y, Guan SY, Deng J, Yang H, Xu W, Xu S, Shao M, Gao X, Xu S, Shuai Z, et al. 2020. B7-H3: a promising therapeutic target for autoimmune diseases. Cell Immunol. 352:104077.
   PubMed Web of Science ®Google Scholar
• Chen Y, Yang H, Xu S, Shen J, Xu W, Shao M, Pan F. 2021. Association analysis of B7-H3 and B7-H4 gene single nucleotide polymorphisms in susceptibility to ankylosing spondylitis in eastern Chinese Han population. Int J Immunogenet. 48(6):500–09.
   PubMed Web of Science ®Google Scholar
• Crossfield SSR, Marzo-Ortega H, Kingsbury SR, Pujades-Rodriguez M, Conaghan PG. 2021. Changes in ankylosing spondylitis incidence, prevalence and time to diagnosis over two decades. RMD Open. 7(3):e001888.
   PubMed Web of Science ®Google Scholar
• Ehrlich M, Lacey M. 2013. DNA methylation and differentiation: silencing, upregulation and modulation of gene expression. Epigenomics. 5(5):553–68.
   PubMed Web of Science ®Google Scholar
• Hanson A, Brown MA. 2017. Genetics and the causes of ankylosing spondylitis. Rheum Dis Clin North Am. 43(3):401–14.
   PubMed Web of Science ®Google Scholar
• Hao J, Liu Y, Xu J, Wang W, Wen Y, He A, Fan Q, Guo X, Zhang F. 2017. Genome-wide DNA methylation profile analysis identifies differentially methylated loci associated with ankylosis spondylitis. Arthritis Res Ther. 19(1):177.
   PubMedGoogle Scholar
• Karagianni P, Tzioufas AG. 2019. Epigenetic perspectives on systemic autoimmune disease. J Autoimmun. 104:102315.
   PubMed Web of Science ®Google Scholar
• Karami J, Mahmoudi M, Amirzargar A, Gharshasbi M, Jamshidi A, Aslani S, Nicknam MH. 2017. Promoter hypermethylation of BCL11B gene correlates with downregulation of gene transcription in ankylosing spondylitis patients. Genes Immun. 18(3):170–75.
   PubMed Web of Science ®Google Scholar
• Kusuda M, Haroon N, Nakamura A. 2021. Complexity of enthesitis and new bone formation in ankylosing spondylitis: current understanding of the immunopathology and therapeutic approaches. Mod Rheumatol. 32(3):484-492
   Web of Science ®Google Scholar
• Ma Y, Fan D, Xu S, Deng J, Gao X, Guan S, Zhang X, Pan F. 2021. Ankylosing spondylitis patients display aberrant ERAP1 gene DNA methylation and expression. Immunol Invest. 1–13. doi:10.1080/08820139.2021.1982965
   Web of Science ®Google Scholar
• Magoč T, Salzberg SL. 2011. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinf (Oxford, England). 27(21):2957–63.
   PubMed Web of Science ®Google Scholar
• Oh Y, Park R, Kim SY, Park S-H, Jo S, Kim T-H, Ji JD. 2021. B7–H3 regulates osteoclast differentiation via type I interferon-dependent IDO induction. Cell Death Dis. 12(11):971.
   PubMed Web of Science ®Google Scholar
• Prasad DV, Nguyen T, Li Z, Yang Y, Duong J, Wang Y, Dong C. 2004. Murine B7-H3 is a negative regulator of T cells. J Immunol. 173(4):2500–06.
   PubMed Web of Science ®Google Scholar
• Ranganathan V, Gracey E, Brown MA, Inman RD, Haroon N. 2017. Pathogenesis of ankylosing spondylitis - recent advances and future directions. Nat Rev Rheumatol. 13(6):359–67.
   PubMed Web of Science ®Google Scholar
• Ritchlin C, Adamopoulos IE. 2021. Axial spondyloarthritis: new advances in diagnosis and management. BMJ (Clin Res Ed). 372:m4447.
   PubMedGoogle Scholar
• Souweidane MM, Kramer K, Pandit-Taskar N, Zhou Z, Haque S, Zanzonico P, Carrasquillo JA, Lyashchenko SK, Thakur SB, Donzelli M, et al. 2018. Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial. Lancet Oncol. 19(8):1040–50.
   PubMed Web of Science ®Google Scholar
• Suh WK, Wang SX, Jheon AH, Moreno L, Yoshinaga SK, Ganss B, Sodek J, Grynpas MD, Mak TW. 2004. The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization. Proc Natl Acad Sci USA. 101(35):12969–73.
   PubMed Web of Science ®Google Scholar
• Sun M, Xie J, Zhang D, Chen C, Lin S, Chen Y, Zhang G. 2021. B7-H3 inhibits apoptosis of gastric cancer cell by interacting with fibronectin. J Cancer. 12(24):7518–26.
   PubMed Web of Science ®Google Scholar
• van der Linden S, Valkenburg HA, Cats A. 1984. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 27(4):361–68.
   PubMed Web of Science ®Google Scholar
• Wu J, Zhang TP, Zhao YL, Li B-Z, Leng R-X, Pan H-F, Ye D-Q. 2019. Decreased H19, GAS5, and linc0597 expression and association analysis of related gene polymorphisms in rheumatoid arthritis. Biomolecules. 10(1):55.
   Web of Science ®Google Scholar
• Wu J, Deng LJ, Xia YR, Leng R-X, Fan Y-G, Pan H-F, Ye D-Q. 2022. Involvement of N6-methyladenosine modifications of long noncoding RNAs in systemic lupus erythematosus. Mol Immunol. 143:77–84.
   PubMed Web of Science ®Google Scholar
• Xu S, Gao X, Ma Y, Deng J, Xu S, Pan F. 2021. Association of methylation level and transcript level in TRAF5 gene with ankylosing spondylitis: a case-control study. Genes Immun. 22(2):101–07.
   PubMed Web of Science ®Google Scholar
• Yan R, Hu Y, Yu P, Wen H, Feng P, Yang S. 2015. Reduced serum B7-H3 levels in patients with ankylosing spondylitis. Inflammation. 38(3):1322–28.
   PubMed Web of Science ®Google Scholar
• Zhang X, Lu J, Pan Z, Ma Y, Liu R, Yang S, Yang S, Dong J, Shi X, Xu S, et al. 2019. DNA methylation and transcriptome signature of the IL12B gene in ankylosing spondylitis. Int Immunopharmacol. 71:109–14.
   PubMed Web of Science ®Google Scholar
• Zhou WT, Jin WL. 2021. B7-H3/CD276: an emerging cancer immunotherapy. Front Immunol. 12:701006.
   PubMed Web of Science ®Google Scholar
• Zhu H, Wu LF, Mo XB, Lu X, Tang H, Zhu X-W, Xia W, Guo Y-F, Wang M-J, Zeng K-Q, et al. 2019. Rheumatoid arthritis–associated DNA methylation sites in peripheral blood mononuclear cells. Ann Rheum Dis. 78(1):36–42.
   PubMed Web of Science ®Google Scholar
• Zhu W, He X, Cheng K, Zhang L, Chen D, Wang X, Qiu G, Cao X, Weng X. 2019. Ankylosing spondylitis: etiology, pathogenesis, and treatments. Bone Res. 7(1):22.
   PubMedGoogle Scholar